Matthew Holt

Track

Insider profile

Positions

Position Company Period
Independent Director Bellerophon Therapeutics Inc None -
Matthew Holt's trades of Bellerophon Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2015-02-23 2015-02-19
B Purchase
47,859 -7.2%
135.26
US$1,172,750 		47,859 -7.2% 135.26 US$1,172,750